International Journal of Cancer

Cover image for Vol. 137 Issue 7

Editor-in-Chief: Professor Peter Lichter, DKFZ, Germany

Impact Factor: 5.085

ISI Journal Citation Reports © Ranking: 2014: 31/211 (Oncology)

Online ISSN: 1097-0215

Recently Published Issues

See all

Read the Latest from IJC

New Content from IJC

IJC Accepted Articles(accepted manuscripts)
Accepted Articles have been accepted for publication in IJC, but have not undergone the editing and proof-correction process. Accepted Articles are citable by DOI.

IJC Early View(e-pub ahead of print)
Early View articles are definitive in format and presented in advance of print publication.

View These Special Section Selections

Read Now

IJC Special Sections

Cancer research in France

Cancer research in France
Kara Rogers and Gilbert M. Lenoir

Oncometabolites-driven tumorigenesis: From genetics to targeted therapy
Aurélie Morin et al.

Recent insights into the biology of neuroblastoma
Gudrun Schleiermacher et al.

Retinoic acid signaling in cancer: The parable of acute promyelocytic leukemia
Julien Ablain and Hugues de Thé

Read all recent IJC Special Section papers!

Follow us on Facebook for the latest news from IJC:

IJC Facebook

Professor Lichter's Top Picks

Read Now

Editor's Choice from IJC

Access the monthly Editor’s Choice article FREE!

2015 (Volume 137)

October (Issue 7)

Treatment of melanoma with a serotype 5/3 chimeric oncolytic adenovirus coding for GM-CSF: Results in vitro, in rodents and in humans
S. Bramante et al. (Pages 1775–1783)

October (Issue 6)

A natural HIV p17 protein variant up-regulates the LMP-1 EBV oncoprotein and promotes the growth of EBV-infected B-lymphocytes: Implications for EBV-driven lymphomagenesis in the HIV setting
D. Martorelli et al. (Pages 1374–1385)

September (Issue 5)

NKT cells act through third party bone marrow-derived cells to suppress NK cell activity in the liver and exacerbate hepatic melanoma metastases
L. Sadegh et al. (Pages 1085 – 1094)

August (Issue 4)

Engineered adenoviruses combine enhanced oncolysis with improved virus production by mesenchymal stromal carrier cells
K. Hammer et al. (Pages 978 – 990)

August (Issue 3)

The rarity of ALDH+ cells is the key to separation of normal versus leukemia stem cells by ALDH activity in AML patients
V. T. Hoang et al. (Pages 525 – 536)

July (Issue 2)

Permissive expansion and homing of adoptively transferred T cells in tumor-bearing hosts
C. Perez et al. (Pages 359 – 371)

July (Issue 1)

CD20 alternative splicing isoform generates immunogenic CD4 helper T epitopes
C. Vauchy et al. (Pages 116 – 126)

2015 (Volume 136)

June (Issue 12)

A comprehensively characterized large panel of head and neck cancer patient-derived xenografts identifies the mTOR inhibitor everolimus as potential new treatment option
K. Klinghammer et al. (Pages 2940 – 2948)

June (Issue 11)

Identification of NY-BR-1-specific CD4+ T cell epitopes using HLA-transgenic mice
A. Gardyan et al. (Pages 2588 – 2597)

Click the button for

Editors' Choice

2014 Joint IJC & Klaus Tschira Stiftung Lectureships

IJC Lectureships

The Joint IJC and Klaus Tschira Stiftung Lectureship at the German Cancer Research Center (DKFZ) in Heidelberg honors three to four leading scientists in the field of cancer research each year. We would like to offer our international readership a taste of these lectures and now present the 2014 videos. Additional videos will be posted following each lecture. We welcome you to view them. The videos from the lectures in 2012 and 2013 can be found under “Special Features”.

Prof Jane Visvader
The Walter and Eliza Hall Institute Melbourne, Australia


Prof Peter W. Laird
University of Southern California, School of Medicine, CA


Prof Dr C. Richard Boland
Baylor University Medical Center Dallas, Texas